Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion

Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion

Bibliographic Details
Main Authors: Gauthier Decool, Carine Domenech, Nathalie Grardel, Adriana Plesa, Imelda Raczkiewicz, Benoit Ducourneau, Philippe Ruminy, Marie-Pierre Pages, Sandrine Girard, Laurène Fenwarth, Claude Preudhomme, Yves Bertrand, Nicolas Duployez
Format: Article
Language:English
Published: Wolters Kluwer 2019-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000193
id doaj-58892bd17f0048e380b9e45edd6cc72a
record_format Article
spelling doaj-58892bd17f0048e380b9e45edd6cc72a2020-11-25T03:22:19ZengWolters KluwerHemaSphere2572-92412019-06-013310.1097/HS9.0000000000000193201906000-00010Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 FusionGauthier DecoolCarine DomenechNathalie GrardelAdriana PlesaImelda RaczkiewiczBenoit DucourneauPhilippe RuminyMarie-Pierre PagesSandrine GirardLaurène FenwarthClaude PreudhommeYves BertrandNicolas Duployezhttp://journals.lww.com/10.1097/HS9.0000000000000193
collection DOAJ
language English
format Article
sources DOAJ
author Gauthier Decool
Carine Domenech
Nathalie Grardel
Adriana Plesa
Imelda Raczkiewicz
Benoit Ducourneau
Philippe Ruminy
Marie-Pierre Pages
Sandrine Girard
Laurène Fenwarth
Claude Preudhomme
Yves Bertrand
Nicolas Duployez
spellingShingle Gauthier Decool
Carine Domenech
Nathalie Grardel
Adriana Plesa
Imelda Raczkiewicz
Benoit Ducourneau
Philippe Ruminy
Marie-Pierre Pages
Sandrine Girard
Laurène Fenwarth
Claude Preudhomme
Yves Bertrand
Nicolas Duployez
Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
HemaSphere
author_facet Gauthier Decool
Carine Domenech
Nathalie Grardel
Adriana Plesa
Imelda Raczkiewicz
Benoit Ducourneau
Philippe Ruminy
Marie-Pierre Pages
Sandrine Girard
Laurène Fenwarth
Claude Preudhomme
Yves Bertrand
Nicolas Duployez
author_sort Gauthier Decool
title Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
title_short Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
title_full Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
title_fullStr Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
title_full_unstemmed Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion
title_sort efficacy of tyrosine kinase inhibitor therapy in a chemotherapy-refractory b-cell precursor acute lymphoblastic leukemia with zc3hav1-abl2 fusion
publisher Wolters Kluwer
series HemaSphere
issn 2572-9241
publishDate 2019-06-01
url http://journals.lww.com/10.1097/HS9.0000000000000193
work_keys_str_mv AT gauthierdecool efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT carinedomenech efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT nathaliegrardel efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT adrianaplesa efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT imeldaraczkiewicz efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT benoitducourneau efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT philipperuminy efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT mariepierrepages efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT sandrinegirard efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT laurenefenwarth efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT claudepreudhomme efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT yvesbertrand efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
AT nicolasduployez efficacyoftyrosinekinaseinhibitortherapyinachemotherapyrefractorybcellprecursoracutelymphoblasticleukemiawithzc3hav1abl2fusion
_version_ 1724609935042412544

Similar Items